TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

4.80$ +0.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

MiMedx Group Inc (MDXG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 64 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MDXG
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
82 87 85 87 84 93 88 99 114 118 59 64 355
15 14 13 15 15 17 17 19 19 19 17 20 75
67 73 72 72 69 76 72 80 95 99 42 44 280
3.1 2.4 2.8 3.0 2.9 3.6 3.3 3.3 3.7 4.8 4.1 2.8 15
53 54 55 55 54 61 60 16 15 73 9.3 13 111
56 58 59 49 58 65 63 68 73 78 58 63 271
11 15 13 23 11 11 8.3 12 22 21 -16 -18 8.8
1.7 1.6 1.7 0.0 0.3 2.5 0.5 0.5 0.8 0.4 0.4
9.4 14 11 23 11 11 8.6 13 23 22 -15 -18 12
0.6 -37 2.3 5.6 3.5 3.8 1.6 3.4 6.1 6.6 -4.5 -2.9 5.3
8.5 53 9.3 18 8.1 7.4 7.0 9.6 17 15 -11 -15 6.2
12 16 14 24 13 14 12 17 29 25 -14 -17 24

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?